Table 4.
Risk of various clinical outcomes up to 5 years in propensity-matched patients.
| Outcomes | Incidence of event at 5 years [ n (%)] | Crude HR (95% CI) | P-value | Adjusted HR (95% CI) | P-value | |
|---|---|---|---|---|---|---|
| Diabetes (n = 316) | Non-diabetes (n = 403) | |||||
| All-cause mortality | 13 (4.5) | 5 (1.7) | 2.66 (0.95–7.47) | 0.063 | 2.56 (0.91–7.24) | 0.076 |
| Cardiac death | 4 (1.4) | 3 (1.0) | 1.36 (0.30–6.06) | 0.690 | 1.18 (0.25–5.50) | 0.835 |
| MI | 22 (7.6) | 24 (8.3) | 0.93 (0.52–1.66) | 0.807 | 0.94 (0.53–1.68) | 0.835 |
| Stroke | 11 (3.8) | 6 (2.1) | 1.88 (0.69–5.07) | 0.216 | 1.00 (0.39–2.60) | 1.000 |
| TVR | 61 (21.1) | 54 (18.7) | 1.13 (0.79–1.64) | 0.502 | 1.13 (0.78–1.64) | 0.509 |
| MACCE | 84 (29.1) | 67 (23.2) | 1.27 (0.92–1.76) | 0.141 | 1.27 (0.92–1.75) | 0.155 |
MI, myocardial infarction; TVR, target-vessel revascularization; MACCE, major adverse cardiac and cerebrovascular events.